Anti-CD94 antibodies are directed against the protein encoded by the gene KLRD1, or 'killer cell lectin-like receptor D1' in humans. The 179-amino acid protein has a reported mass of 20,513 daltons and the cellular localization is predicted to be membrane-associated. Glycosylation sites have been reported.